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Semmary: Selected serum samples with different isoamylase patterns, äs revealed by agarose gel electro-
phoresis, were analysed by the Phadebas amylase test, and by using p-nitrophenyl-maltoheptaoside äs the
Substrate. The products with the latter Substrate were examined by high performance liquid chromatography
(HPLC). For some samples, different catalytic activities were registered by the two amylase methods. In these
cases, electrophoresis showed a double pancreatic band associated with increased pancreatic amylase catalytic
activity, or an abnormal, broad salivary band associated with increased salivary enzyme catalytic activity. The
stoichiometric factors for most of these samples, calculated from the amount of p-nitrophenol detected after
HPLC, differed from the mean values.
Wirkungs-Muster von Amylase im Serum bei Anwendung von p-Nitrophenyl-maltoheptaosid als Substrat
Zusammenfassung: Ausgewählte Proben mit verschiedenen Isoamylasemustern, untersucht mit der Agarose-
Elektrophorese, wurden sowohl mit dem Phadebas- Amylase-Test als auch mit p-Nitrophenyl-maltoheptaosid
als Substrat untersucht. Die mit dem letzteren Substrat erhaltenen Produkte wurden mit der HPLC-Methode
geprüft. Wir fanden bei einigen Proben Abweichungen in den Amylaseaktivitäten zwischen den beiden Amy-
lase-Methoden. In diesen Fällen war entweder ein doppeltes Band des pankreatischen Isoenzyms mit erhöh-
ter Pankreasamylaseaktivität vorhanden oder ein abnorm breites Speichelamylaseband wurde bei erhöhter
Speichelamylaseaktivität gesehen. Die stöchiometrischen Faktoren für diese Proben, berechnet nach der
Menge p-Nitrophenol, die bei der Analyse mit HPLC gefunden wurde, unterschieden sich von den Mittel-
werten der meisten Proben.
Introduction
Several authors have studied the reaction mecha-
nism of purified human pancreatic or salivary amy-
lase (l,4-a-£)-glucap glucänohydrol^se, EC 3.2.1.1)
using p-nitröphenyKmaltoheptaoside äs Substrate
(1-^5). Using this Substrate and amylase in the ab-
sence and presence of -glucpsidase (a-D-glucoside
glucohydrolase, EC 3.2.1.20), Hagele etal. quanti-
tated the amount of p-nitfophenol produced and
proposed that a stoichiometric factor of 3 (calculated
äs the reciprocal of /?-nitrophenol) should be used in
the calculation of amylase catalytic activity (5). We
have examined the reaction mechanism of amylase
with p-nitrophenyl-maltoheptaoside using authentic
patient samples with different isoamylase patterns.
Materials and Methods
All the chemicals and column material required for high perfpr-
mance liquid chromatography (HPLC) were purchased from
Merck (Darmstadt, West Germany). Purified human serum albu-
min was obtained from Behringwerke (Calbiochem-Behring
Corp. La Jolla CA 92037). p-Nitrophenyl-maltoheptaoside and
-glucosidase were purchased from Boehringer Mannheim
(Stockholm, Sweden). p-Nitrophenyl derivates of maltotriose,
maltotetraose, maltopentaose, and purified human pancreatic and
salivary amylases were gifts from Boehringer Mannheim (Tutzing,
West Germany). Phadebas amylase test was purchased from
Pharmacia Diagnostica (Uppsala, Sweden).
Serum samples were selected on the basis of the isoamylase patt-
erns determined by the electrophoretic method of Skude (6). To-
tal amylase catalytic activities were determined with the Phadebas
amylase method and p-nitrophenyl-maltoheptaoside colorimetric
method (Boehringer Mannheim) adapted to Greiner Selective
Analyzer (GSAII, Greiner Electronics AG, Langenthal, Switzer-
land) (7). The GSA II analyzer was calibrated with a serum pool
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whose amylase activity had been determined by the Phadebas
methocl. This procedure simplified method comparisons,
For HPLC, 25 μΐ sample were incubated at 37 °C with 500 μΐ of
5mmol/l p-nitrophenyl-maltoheptaoside in buffer (50mmol/l
NaH2PO4 and 50 mmol/1 NaCl, pH 7.1). When α-glucosidase was
included in the incubations, a catalytic concentration of approxi-
mately 30 kU/1 in the reaction mixture was used. The amylase
reaction was stopped by adding 500 μΐ acetonitrile, 75 μΐ of l mol/I
H.iPO4 and l ml of a solution containing equal volumes of ace-
tonitrile and KH2PO4, adjusted to pH 7.1. The HPLC System was
s described by Hagele et al. (5) except that no guard column was
used. Peak areas were integrated electronically. Some of the sam-
ples were also incubated with p-nitrophenyl-maltotetraoside and
-maltotrioside.
The effect of salivary amylase on the reaction mechanism was
tested by adding increasing quantities of saliva to a constant pan-
creatic amylase catalytic activity. All the samples were diluted
once more to the same final amylase catalytic activity.
Least square regression analyses and Wilcoxon test for pair differ-
ences were used to compare amylase activities obtained by the
Phadebas and the p-nitrophenyl-maltoheptaoside colorimetric
test (Boehringer Mannheim). The data from HPLC studies (in the
absence of α-glucosidase) were used to study the relationships be-
tween the reaction products p-nitrophenyl-maltoside, -maltotrio-
side and -maltotetraoside. The stoichiometric factors were calcu-
lated for the sampies incubated with p-nitrophenyl-maltoheptao-
side in the presence of α-glucosidase. Mathematically, this is the
reciprocal of the amount of p-nitrophenol detected after HPLC.
Results and Discussion
All the analyses were performed in duplicate. The
comparison of amylase activities obtained with the
Phadebas method and with thep-nitrophenyl-malto-
heptaoside colorimetric method are shown in ta-
ble 1. A good correlation between the two methods
was obtained for samples with normal isoamylase
pattern. In the case of samples with pancreatic amy-
lase dominance, the catalytic activities with the/?-ni-
trophenyl-maltoheptaoside method were slightly
lower (by approximately 5%) for most samples, with
the exception of four samples where the catalytic ac-
tivities were between 15 and 30% lower than corre-
sponding catalytic activities with the Phadebas meth-
od. Double pancreatic band (fig. 1) were seen in
three of these samples. With increased salivary amy-
lase, the catalytic activities with the p-nitrophenyl-
maltoheptaoside colorimetric method were generally
slightly higher (by approximately 4%), with the ex-
ception of five samples where the activities with the
p-nitrophenyl-maltoheptaoside colorimetric method
were between 50 and 70% higher than the corre-
sponding catalytic activities with the Phadebas meth-
od. These samples had abnormal, broad salivary
bands (fig. 1). The regression equation for all the
samples in tablel was y = 0.95 χ-h 0.52 μkat/l
(r = 0.983). This equation reverted to
y = 0.99 χ - 0.08 μ1ς3ΐ/ΐ (η = 0.996) when the sam-
ples with the large discrepancies mentioned above
were excluded from the statistical analysis.
Tab. 1. Comparison of amylase catalytic activities determined by
the Phadebas and by the p-nitrophenyl-maltoheptaoside
colorimetric methods.


























a) P denotes pancreatic amylase.
b) S denotes salivary amylase.
χ is the reference method (Phadebas) and
y is the /7-nitrophenyl-maltoheptaoside colorimetric method.
c) The pair difference tests were not significant for normal P and
S, but significant for P > 0.65 and S > 0.55 (p < 0.01).
l \ikal is the enzyme catalytic activity which converts l μιηοΐ of




Fig. 1. Electrophoretogram of amylase isoenzymes. The electro-
phpresis and detection of the amylase isoenzymes
(P = pancreatic; S = salivary) isoenzymes was performed
according to Skude (6). v* ^ "T
1) Normal sample 4) increased P and S
2) Increased P 5) Double P band
3) Increased S 6) Broad S band
For HPLC studies, the retention times of the p-ni-
trophenylated products obtained after the reaction
of amylase were standardized with authentic/^nitro-
phenyl-maltotrioside, -maltotetraoside, -maltoperi-
taoside and -maltoheptaoside. A deviation of ± l
min was accepted. The column was repacked wheri
deviations in retention times were greater than the
tolerance levels stated. The coefficient of Variation
for peak Integration was not llowed to exceed 5%
for duplicate analyses. We performed preliminary
experirnents using p-nitrpphenyl-maltoheptaoside
with different amylase catalytic activities, different
incubation times and dil tion media such s NaCl
and albumin. As a result of these studies, the sub-
•strate was incubated at 37 °C for 30 minutes using
5 μkat/l amylase catalytic cortc^ptration (the samples
were diluted, if necessary, with 50 g/l albumin).
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We found that between 4 and 7% of p-nitrophenyl-
maltoheptaoside was hydrolysed by the samples with
either normal isoamylase distribution or with pan-
creatic amylase dominance (P > 0.65). In the case of
samples with increased salivary amylase (S > 0.55),
between 4 and 12% of p-nitrophenyl-maltoheptao-
side was hydrolysed. The samples with the broad sa-
livary band were responsible for more hydrolysis.
Whereas p-nitrophenyl-maltoside, -maltotrioside
and -maltotetraoside were the inain reaction pro-
ducts, p-nitrophenyl-glucoside was found in 3 of the
samples with the abnormal salivary bands. We found
that the ratio of p-nitrophenyl-maltotetraoside to
-maltotrioside depended on the isoamylase pattern.
A mean ratio of 1.6 was obtained for purified pan-
creatic amylase and for the samples where P > 0.65.
A mean ratio of 2.0 was found for saliva, purified
salivary amylase and samples with S > 0.55. Howev-
er, in the case of 4 samples with a broad salivary am-
ylase band, this ratio varied between 1.3 and 1.4. In
the fifth sample belonging to this category, the ratio
was 1.8. We also observed that more p-nitrophenyl-
maltoside was produced in the samples with salivary
amylase dominance using either p-nitrophenyl-mal-
toheptaoside, -maltotetraoside or -maltotrioside s
subtrates.
Adding increasing catalytic activities of salivary am-
ylase to a constant pancreatic component resulted in
an increase of the p-nitrophenyl-maltotetraoside to
-maltotrioside ratios (fig. 2), and in more production
of p-nitrophenyl-maltoside, despite the fact that the
final amylase catalytic activity concentration in each
sample was kept constant at 5 μkat/l.
For the hydrolysis of p-nitrQphenyl-maltoheptao-
side, the main pathway appears to be the production
of p-nitrophenyl-maltotrioside and -m ltotetraoside.
It appears feasible that more of p-nitrophenyl-mal-
totrioside is produced by pancreatic amylase, and
more of p^nitrophettyl^maltotetraoside is produced
by salivary amylase. Tw alternative pathways may
be responsible for the production of p-nitrophenyl-
maltoside. First, a primafy cleavage from p-nitro-
phenyl-maltoheptaoside. Second, a further cleavage
of either p-nitrophenyUmaltotrioside or -maltote-
traoside, and any p-nitrophenyl-maltopentaoside
produced. When we used p-nitrophenyl-maltotrio^
side s the Substrate, we found p-nitrophenylgluco-
side and -maltoside s the products. Since p-nitro-
phenyl-glucoside was found in only three of the sam^·
ples, we concluded that p-nitrophenyl-maltotrioside
is not likely to be subjected to further degradation in
the presence of excess p-nitrophenyl-maltopheptao-
side. However, it is evident from the HPLC studies
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Fig. 2. Effect of salivary amylase on the /?-nitrophenyl-maltote-
traoside/-maltotrioside ratio. Three samples (A, B and C),
containing between 0.50 and 0.85 pancreatic amylase,
were diluted with saliva such that the salivary amylase ca-
talytic activity increased whereas the pancreatic catalytic
activity was constant. The samples were then diluted to
final catalytic concentrations of 5 \ikat/\ and incubated
with p-nitrophenyl-maltoheptaoside s described in
"Materials and Methods". The products were separated
by HPLC and the p-nitrophenyl-maltotetraoside/-malto-
trioside ratios were calculated.
ther, at least by samples with salivary amylase domi-
nance.
The calculation of the stoichiometric factor is based
on the amylase reaction products that can be hydro-
lysed to free p-nitrophenol by a-glucosidase (5).
These include p-nitrophenyl-glucoside, -maltoside
and -maltotrioside. We calculated the stoichiometric
factors from the amount of p-nitrophenol detected
by HPLC (when a-glucosidase was included in the
incubations). The mean stoichiometric factor for
samples showing a normal isoamylase pattern was
2.99 (SD 0.16), and 3.25 (SD 0.31) for samples with
P > 0.65. The mean factor for samples with S > 0.55
was 2.72 (SD 0.52). The most interesting deviations
which result in discrepancies between the amylase
catalytic activities are shown in table 2. It is evident
that the stoichiometric factors in these samples vary
from 2.0 to 4.0. In those cases where the stoichio-
metric factor was close to 3.0, the amylase catalytic
activities by either the Phadebas method or the p-ni-
trophenyl-maltoheptaoside colorimetric method
were comparable. When the factor was > 3.0, the
catalytic activities with the Phadebas method were
higher. This was seen in samples with pancreatic am-
ylase dominance and particularly with samples dis-
playing a double pancreatic amylase band. With a
stoichiometric factor <3.0, the catalytic activities
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a) The Stoichiometric factor is the reciprocal of the amount of p-nitrophenol detected.
b) p-Nitrophenyl-maltoheptaoside colorimetric method, Boehringer Mannheim.
c) Samples with double pancreatic (P) band.
d) Samples with abnormal, broad salivary (S) band.
with the Phadebas method were lower. This was seen
in samples containing the abnormal, broad salivary
band. In all the cases where the Stoichiometric factor
deviated significantly from 3.0, the HPLC examina-
tion of the products revealed that all the p-nitro-
phenyl-maltoside or -maltotrioside was not hydro-
lysed by -glucosidase. The fact that more p-nitro-
phenol was detected with the samples containing the
broad salivary band can be explained by our obser-
vation that more of Substrate was hydrolysed by
these samples.
In conclusion, we can state that for a great majority
of the samples, the reaction mechanism and stoichi-
ometry agree well with the results of Hagele et al (5).
However, it is importaiit to bear in mind that in söme
cases of pancreatitis, the amylase catalytic activity
with the p-nitrophenyl-maltoheptaoside colorimetric
method may be underestimated. Conversely, the en-
zyme catalytic activity in some of the samples con-
taining predominantly salivary amylase may be over-
estimated.
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